We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

84 hedge funds and large institutions have $601M invested in PTC Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

200% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 12

29% more funds holding

Funds holding: 65 → 84 (+19)

0% more capital invested

Capital invested by funds: $600M → $601M (+$1.09M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+19
Holders Change %
+29.23%
% of All Funds
2.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
36
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SAM
Sectoral Asset Management
Quebec, Canada
+$12.9M
2
Millennium Management
Millennium Management
New York
+$9.57M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.13M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$5.1M
5
BFA
BlackRock Fund Advisors
California
+$4.9M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$25.7M
2
Jennison Associates
Jennison Associates
New York
-$22.5M
3
O
OrbiMed
New York
-$14M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$12.4M
5
CAM
Cormorant Asset Management
Massachusetts
-$8.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$118M -$7.45K -348 -0%
BCPEM
2
Bain Capital Public Equity Management
Massachusetts
$74.8M – – –
CS
3
Credit Suisse
Switzerland
$59.4M +$93K +4,346 +0.2%
SAM
4
Sectoral Asset Management
Quebec, Canada
$40.5M +$12.9M +603,372 +64%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$39.6M +$1.23M +57,415 +4%
BFA
6
BlackRock Fund Advisors
California
$23.6M +$4.9M +228,782 +34%
GIM
7
Granahan Investment Management
Massachusetts
$23M -$449K -20,960 -2%
State Street
8
State Street
Massachusetts
$22.1M +$3.26M +152,382 +22%
Westfield Capital Management
9
Westfield Capital Management
Massachusetts
$19.1M +$5.1M +238,110 +48%
PA
10
Perceptive Advisors
New York
$17.6M – – –
JHIU
11
Janus Henderson Investors US
Colorado
$14.7M -$1.04M -48,765 -8%
Vanguard Group
12
Vanguard Group
Pennsylvania
$14.3M +$1.77M +82,849 +18%
Millennium Management
13
Millennium Management
New York
$11.7M +$9.57M +446,881 New
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$11.2M +$9.13M +426,666 New
Franklin Resources
15
Franklin Resources
California
$10.4M – – –
TAM
16
Tocqueville Asset Management
New York
$7.11M +$4.22M +197,313 +265%
BIT
17
BlackRock Institutional Trust
California
$6.83M +$2.58M +120,600 +86%
NI
18
Numeric Investors
Massachusetts
$6.79M +$178K +8,311 +3%
PI
19
Putnam Investments
Massachusetts
$5.73M -$17.1K -800 -0.4%
O
20
OrbiMed
New York
$4.66M -$14M -652,000 -79%
Northern Trust
21
Northern Trust
Illinois
$4.14M +$183K +8,554 +6%
CAM
22
Cormorant Asset Management
Massachusetts
$3.92M -$8.56M -400,000 -73%
SFM
23
Sphera Funds Management
Israel
$3.92M +$3.21M +150,000 New
CNB
24
City National Bank
California
$3.84M +$1.7M +79,262 +117%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$3.67M +$1.87M +87,261 +164%
1
2 3 4

PTCT Hedge Fund Activity: Q2 2014 in Review

84 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2014, worth a combined $601M — up 0.18% from $600M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PTCT positions and 8 closed out — a net gain of 19 holders — while 36 added to existing stakes and 12 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $12.9M. The largest seller was RA Capital Management, exiting entirely with an estimated $25.7M sold.

  • 84 institutional investors held PTC Therapeutics (PTCT) as of Q2 2014, up from 65 in Q1 2014.
  • Funds reported $601M of PTC Therapeutics stock for Q2 2014, up 0.18% quarter-over-quarter.
  • 27 funds opened new PTC Therapeutics positions in Q2 2014 and 8 closed out, a net change of +19 holders.
  • The largest PTC Therapeutics buyer in Q2 2014 was Sectoral Asset Management, an estimated $12.9M added.
  • The largest PTC Therapeutics seller in Q2 2014 was RA Capital Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2014.